Mortality and cardiovascular disease progression in patients with and without diabetes mellitus during long term follow up after drug-eluting stent (DES) implantation

被引：0
|
作者：
Raber, L. [1 ]
Wenaweser, P. [1 ]
Cook, S. [1 ]
Vogel, R. [1 ]
Togni, M. [1 ]
Khattab, A. [1 ]
Moschovitis, A. [1 ]
Meier, B. [1 ]
Juni, P. [2 ]
Windecker, S. [1 ]
机构：
[1] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland
[2] Univ Hosp Bern, CTU, CH-3010 Bern, Switzerland
来源：
EUROPEAN HEART JOURNAL | 2010年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：666 / 667
页数：2
相关论文
共 50 条
  • [41] Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes
    Hong, S. J.
    Kim, M. H.
    Ahn, T. H.
    Ahn, Y. K.
    Bae, J. H.
    Shim, W. J.
    Ro, Y. M.
    Lim, D-S
    HEART, 2006, 92 (08) : 1119 - 1124
  • [42] Relationship between hyperhomocysteine and long-term outcome of coronary artery disease patients after drug-eluting stent implantation
    鄢高亮
    China Medical Abstracts(Internal Medicine), 2016, 33 (01) : 25 - 26
  • [43] Different Patterns of Vascular Response Between Patients With or Without Diabetes Mellitus After Drug-Eluting Stent Implantation Optical Coherence Tomographic Analysis
    Tanaka, Nobuyoshi
    Terashima, Mitsuyasu
    Rathore, Sudhir
    Itoh, Tsuyoshi
    Habara, Maoto
    Nasu, Kenya
    Kimura, Masashi
    Itoh, Tatsuya
    Kinoshita, Yoshihisa
    Ehara, Mariko
    Tsuchikane, Etsuo
    Asakura, Keiko
    Asakura, Yasushi
    Katoh, Osamu
    Suzuki, Takahiko
    JACC-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (10) : 1074 - 1079
  • [44] Glycosylated Hemoglobin Is a Predictor of Major Adverse Cardiac Events after Drug-Eluting Stent Implantation in Patients with Diabetes Mellitus
    Ueda, Hiroyasu
    Mitsusada, Nobuhiro
    Harimoto, Kuniyasu
    Miyawaki, Masami
    Yasuga, Yuji
    Hiraoka, Hisatoyo
    CARDIOLOGY, 2010, 116 (01) : 51 - 57
  • [45] Impact of diabetes mellitus on the early-phase arterial healing after drug-eluting stent implantation
    Takayuki Ishihara
    Yohei Sotomi
    Takuya Tsujimura
    Osamu Iida
    Tomoaki Kobayashi
    Yuma Hamanaka
    Takashi Omatsu
    Yasushi Sakata
    Yoshiharu Higuchi
    Toshiaki Mano
    Cardiovascular Diabetology, 19
  • [46] Impact of Pioglitazone on Cardiovascular Events in Patients with Diabetes Mellitus after Drug-eluting Stent Implantation: Evidence from 3-Year Follow-up Results of the J-DESsERT Trial
    Yokoi, Hiroyoshi
    Nakamura, Masato
    Muramatsu, Toshiya
    Matsuyama, Yutaka
    Okada, Hisayuki
    Ochiai, Masahiko
    Suwa, Satoru
    Nanto, Shinsuke
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B71 - B72
  • [47] Impact of Coronary Lesion Complexity on Drug-Eluting Stent Outcomes in Patients With and Without Diabetes Mellitus
    Kedhi, Elvin
    Genereux, Philippe
    Palmerini, Tullio
    McAndrew, Thomas C.
    Parise, Helen
    Mehran, Roxana
    Dangas, George D.
    Stone, Gregg W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (20) : 2111 - 2118
  • [48] The Impact of Coronary Lesion Severity on Drug-eluting Stent Outcomes in Patients with and without Diabetes Mellitus
    Kedhi, Elvin
    Genereux, Philippe
    Palmerini, Tullio
    McAndrew, Tom
    Parise, Helen
    Dangas, George
    Mehran, Roxana
    Ben-Yehuda, Ori
    Stone, Gregg
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B7 - B7
  • [49] Impact of Pioglitazone on Cardiovascular Events in Patients with Diabetes Mellitus after Drug-Eluting Stent Implantation: Evidence from 3-Year Follow-up Results of the J-DESsERT Trial
    Yokoi, Hiroyoshi
    Nakamura, Masato
    Muramatsu, Toshiya
    Nanto, Shinsuke
    DIABETES, 2014, 63 : A296 - A296
  • [50] Impact of diabetes mellitus on the early-phase arterial healing after drug-eluting stent implantation
    Ishihara, Takayuki
    Sotomi, Yohei
    Tsujimura, Takuya
    Iida, Osamu
    Kobayashi, Tomoaki
    Hamanaka, Yuma
    Omatsu, Takashi
    Sakata, Yasushi
    Higuchi, Yoshiharu
    Mano, Toshiaki
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
12345